GDF-15 as a risk stratification biomarker for cardiovascular disease

Int J Cardiol. 2019 Oct 1:292:246-247. doi: 10.1016/j.ijcard.2019.06.009. Epub 2019 Jun 8.

Authors

Stergios Tzikas¹, Vassilios Vassilikos², Till Keller³

Affiliations

¹ 3rd Department of Cardiology, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: tzikas@gmail.com.
² 3rd Department of Cardiology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ Division of Cardiology, Department of Internal Medicine III, Goethe University Frankfurt, Frankfurt, Germany.

PMID: 31204068
DOI: 10.1016/j.ijcard.2019.06.009

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers
Cardiovascular Diseases*
Growth Differentiation Factor 15
Humans
Myocardial Infarction*
Risk Assessment

Substances

Biomarkers
Growth Differentiation Factor 15